This Week in Psychedelics - 1.22.21

Cannabis

• France launches public consultation on legalising cannabis (France24)

• UFC ditch marijuana ban but fighters warned to ‘temper enthusiasm’ after Usada rule change (The Independent)

• Biden Taps Marijuana Legalization Supporter To Lead Democratic National Committee (Marijuana Moment)

• American Medical Association Asks Court To Overturn Medical Marijuana Vote In Mississippi (Marijuana Moment)

• Arizona: Adult Use Marijuana Sales On Track to Begin This Month (NORML)

• This Michigan marijuana dispensary is giving free weed to anyone who got the COVID-19 vaccine (Detroit Metro Times)

• Trump Grants Clemency To Marijuana Prisoners On Last Day In Office (Marijuana Moment)

• Study: Nearly Half of Medical Cannabis Users Cease Using Opioids for Pain After Twelve Months (NORML)

• Congressman Files First Federal Marijuana Reform Bill Of 2021 (Marijuana Moment)

• Could Medical Cannabis Help with the Treatment of Movement Disorders? (Canex)

• Latest Canadian cannabis recalls include melting vape pens, moldy bud (Marijuana Business Daily)

• Virginia Marijuana Legalization Bill Approved By Senate Committee, With Home Cultivation Provisions Intact (Marijuana Moment)

• “Game changer” for the sector: First cannabis company expected to list on LSE next month (Cannabis Health News)

• Police Find 1st 'Cannabis Factory' In London's Financial District, Destroy 826 Plants (NPR)

• Hash landing: New Zealand police ditch annual helicopter hunt for cannabis dens (The Guardian)

• Phytol cited as potentially dangerous cannabis vape ingredient (Marijuana Business Daily)

• Study: Cannabis Use Associated with Reduced Alcohol Intake Among Treatment-Seeking Drinkers (NORML)

• Research establishes antibiotic potential for cannabis molecule (ScienceDaily)

• Women who use cannabis may have harder time conceiving (Healio)

• How Some THC Is Legal — For Now (Rolling Stone)

Magic Mushrooms

• Florida Lawmaker Introducing Psilocybin Mushroom Legalization (Forbes)

• Unique magic mushroom microdosing study to begin in Australia (New Atlas)

• How Mixing Mushrooms and MDMA Affects Your Body and Brain (VICE)

• Patient hopes Canada will introduce regulations for treatment with 'magic mushrooms' (CTV News)

• BC Craft Supply Co Announces Letter of Intent with Psilocybin Research and Development Company Ava Pathways (Globe Newswire)

MDMA

• MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD (Psilocybin Alpha)

Ayahuasca

• Insight into Ayahuasca’s Antidepressant Effects (Psychedelic Science Review)

5-MeO-DMT

• New Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate (Psychedelic Science Review)

Synthetic Cannabinoids

• NCSA: Synthetic cannabis a cause for concern (Loop Barbados)

Ketamine

• Ketamine Clinicians Publish Ethical Guidelines to Raise Treatment Standards (Lucid News)

• Colorado officials resume review of ketamine program after Elijah McClain's death (CNN)

• PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders (Psilocybin Alpha)

Miscellaneous

• Icelandic Government Proposes Drug Decriminalisation (The Reykjavik Grapevine)

• Peter Thiel-backed psychedelics start-up targets schizophrenia ahead of IPO (CNBC)

• Psychedelic Therapy Schools Are Popping Up Like Mushrooms (Bloomberg)

• The Biden Administration and Drug Policy: Expectation Versus Reality (Filter)

• North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF? (Psilocybin Alpha)

• A New Supreme Court RFRA Ruling May Be a Boon to Psychedelic Religions (Chacruna)

• Senator wants to 'lock in' 2020 drug laws (Idaho Press)

• NeonMind Lists on the Frankfurt Stock Exchange (Psilocybin Alpha)

• Is Psychedelic Medicine the Antidote to Anti-Black White Racism in the US? (Chacruna)

• The Therapeutic Potential of Psychedelics and Nature Explored in New Study (Lucid News)

• Psychedelic Authoritarianism Harm Reduction: “QAnon Shaman” Edition (Psymposia)

• Here’s What’s Missing From Conversations About Psychedelic Integration (DoubleBlind)

• Attorney General Merrick Garland a Disheartening Prospect (Filter)

• Dopamine Release and Duration of Action: Rules of Thumb to Predict Addictive Potential of Phenethylamines (Spirit Pharmacist)

• Ergot in Canada: A Lost Tradition? (Chacruna)

• BetterLife Pharma Is Developing Second Generation Psychedelics: Drugs That Leave Out The Trip (Forbes)

• Former Defence Force chief Chris Barrie supports increased accessibility of psychedelic drugs (The Canberra Times)

• Could Biden Make His Country’s Global Drug War Even More Imperialist? (Filter)

• What Will The Psychedelics Space Look Like In 2021? Experts Weigh In (Yahoo! Finance)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.15.21

Cannabis

• South Dakota: Republican Governor Officially Backing Litigation to Reject Voter-Approved Marijuana Legalization Initiative (NORML)

• Montana Lawmakers Reject Funding To Implement Voter-Approved Marijuana Legalization Program (Marijuana Moment)

• Mississippi: Medical Organizations Join Legal Fight to Overturn Election Result Legalizing Medical Cannabis Access (NORML)

• Amsterdam doubles down on plans to restrict tourist access to cannabis coffee shops (CNN)

• New Jersey Is ‘On The Verge’ Of Implementing Marijuana Legalization, Governor Says In State Of The State Speech (Marijuana Moment)

• Mexico releases long-awaited medical cannabis regulations (Marijuana Business Daily)

• Activists Give Out Free Marijuana To Encourage COVID Vaccination With ‘Joints For Jabs’ Campaign (Marijuana Moment)

• USDA Releases Final Rule For Hemp, Two Years After Crop Was Federally Legalized (Marijuana Moment)

• UK grants second only licence to grow medical marijuana (Financial Times)

• Virginia Governor Unveils Bill To Legalize Marijuana As Lawmakers Schedule First Hearing (Marijuana Moment)

• New Mexico Governor Says Marijuana Legalization Is A 2021 Priority (Marijuana Moment)

• Kansas Lawmakers Push To Legalize Medical Marijuana In 2021 (Marijuana Moment)

• Colorado authorities issue recall of contaminated cannabis (Marijuana Business Daily)

• USDA Approves Hemp Regulatory Plans From Rhode Island And Another Indian Tribe (Marijuana Moment)

• The Future of Fully Legal Cannabis (Playboy)

• Top Texas Lawmakers Say Medical Marijuana Expansion Is On The Table For 2021 (Marijuana Moment)

• Survey: Most Americans Say Marijuana Possesses Less Abuse Potential Than Alcohol (NORML)

• North Dakota Activists Submit 2022 Marijuana Legalization Ballot Initiative (Marijuana Moment)

• North Dakota Lawmakers File Bill To Significantly Expand Marijuana Decriminalization Law (Marijuana Moment)

• Legalizing marijuana boosts junk food sales (The Academic Times)

• Medical Marijuana Leads To Reduced Opioid Use, New Study Finds (Marijuana Moment)

• Cannabis dispensaries struggle to find financial support amid pandemic (KRON4)

• FDA Unveils Plan To Fill CBD Research Gaps With ‘Real-World Data’ In 2021 (Marijuana Moment)

• Introducing Mode: The world's first smart cannabis dosing device (KVVU-TV)

• Arizona Prepares To Accept Marijuana Applications Next Week As New Draft Legalization Rules Are Issued (Marijuana Moment)

LSD

• LSD Could Be the Key to Alleviating the Mental Health Crisis—if Government Allows It (Foundation for Economic Education)

• MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers (Psilocybin Alpha)

Magic Mushrooms

• Psychedelic Mushrooms Grew in a Man's Veins After He Injected Them (Gizmodo)

• NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity (Psilocybin Alpha)

• Psilocybin is Being Studied to Help Treat Autism Spectrum Disorder (Baystreet)

• Psilocybin produces an immunology-related genetic response in the prefrontal cortex of pig brains (PsyPost)

• CBDV Begins Research on Psilocybin with Section 56 Exemption from Health Canada (Psilocybin Alpha)

• Core One Labs Announces Breakthrough in Solving Psilocybin Dosing Problems by Introducing Biosynthetic Psilocybin to its Patented Thinstrip Delivery Method (AccessWire)

• Silo Pharma Provides Details of Patent License Agreement for Psilocybin and Cancer Applications (GlobeNewswire)

• Revive Therapeutics Announces Research Collaboration with North Carolina State University for Natural Biosynthesis Enzymatic Platform To Develop Psilocybin (Psilocybin Alpha)

MDMA

• Should You Say “I Love You” While on MDMA? (DoubleBlind)

• Awakn Life Sciences Appoints CRO to Conduct Phase II Study of MDMA as a Treatment for Alcohol Use Disorder (Psilocybin Alpha)

Peyote

• Inside a Massive, Illicit Peyote Ceremony During Mexico's COVID Lockdown (VICE)

Iboga

• Ibogaine vs. Iboga Alkaloids for Treating Addiction (Psychedelic Science Review)

Nitrous Oxide

• Police investigation launched after cargo of nitrous oxide canisters discovered in Ribble Valley (Burnley Express)

Ketamine

• A Deadly ‘Ketamine Cocktail’ Is Causing Overdoses on the Streets of Bangkok (VICE)

• Novamind Expands Psychedelic Medicine Access in Utah (Psilocybin Alpha)

Miscellaneous

• Somerville, Massachusetts Decriminalizes Naturally Occurring Psychedelics (DoubleBlind)

• COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care (COMPASS Pathways)

• New York, Virginia And Other States Consider New Drug Decriminalization Bills (Marijuana Moment)

• The World's ‘Largest Illegal Darknet Marketplace’ has Been Shut Down (VICE)

• UFC looks into Johns Hopkins study on psychedelic drugs as potential therapy for fighters (ESPN)

• Michigan Prosecutor Won’t Pursue Most Marijuana Or Psychedelics Cases, ‘Regardless Of The Amount’ (Marijuana Moment)

• DEA Agents Report Agency’s Lack of Basic COVID-19 Safety Measures (Filter)

• When Getting High Is a Hobby, Not a Habit (New York Times)

• How This Black-Led Psychedelic Collective Is Combining Anti-Racism With ‘Sacred Plant Medicine’ (Vogue)

• Eleusis Accelerates Psychedelic Drug Discovery and Development Team with Appointment of David Nichols, Ph.D., as Director of Molecular Pharmacology (Psilocybin Alpha)

• Coping with Antidepressants and Psychedelics (Spirit Pharmacist)

• Psychedelic Illusions are Not Pathological, and May Even Help You See Better (Chacruna)

• Engineering Psychoplastogens: Toward a Safer Alternative for Treating Depression (Psychedelic Science Review)

• Silo Pharma Enters into Sponsored Research Agreement for Potential Multiple Sclerosis Treatment Approach with University of Maryland, Baltimore (Psilocybin Alpha)

• Revealing Trends in Russia’s Dark-Web Drug Markets (TalkingDrugs)

• Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectometer (Cision)

• Having A Bad Trip On Psychedelics: Is There Some Value? (Healing Maps)

• The Emerging Revival of Psychedelics in Neuroscience (Psychology Today)

• Mental Health Demand For Development Of Psychedelic Drug Therapies Is Increasing (PR Newswire)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.8.21

Cannabis

• What The New Democratic-Controlled Senate Means For Federal Marijuana Legalization In 2021 (Marijuana Moment)

• These States Are The Most Likely To Legalize Marijuana In 2021 (Marijuana Moment)

• Incarcerated Patients Have A Right To Use Medical Marijuana, New Mexico Judge Rules (Marijuana Moment)

• Illinois: Governor Vacates Half a Million Past Marijuana Convictions (NORML)

• Virginia Lawmaker Introduces Bill To Legalize Marijuana In 2021 (Marijuana Moment)

• New Bill On Underage Marijuana Possession Could End New Jersey Legalization Stalemate Between Governor and Lawmakers (Marijuana Moment)

• Study: Marijuana Use Not Associated with Increased Risk of Cardiovascular Disease (NORML)

• Scientists Cite Obscure Federal Marijuana Memo In Scheduling Case Against DEA (Marijuana Moment)

• Mother fears son could die as Brexit stops medical cannabis supply (The Guardian)

• Biden AG Pick Merrick Garland Wants To Defer To DEA On Marijuana Science And Classification (Marijuana Moment)

• California: No Uptick in Frequency of Marijuana Use by Young Adults Following Adult-Use Legalization (NORML)

• New York Governor Unveils Updated Marijuana Legalization Plan For 2021 (Marijuana Moment)

LSD

• Here’s What Happens When Animals Eat LSD (DoubleBlind)

Magic Mushrooms

• This Former Latter-day Saint Politician Started a Psilocybin Church—But Is it Legal? (DoubleBlind)

• The Effects of Psilocybin on Morality and Empathy (Psychedelic Science Review)

• Alberta Palliative Patient Successfully Undergoes First Legal Psychedelic-Assisted Therapy in Alberta, Initial Outcomes Exceed Expectations (Psilocybin Alpha)

• Will psychedelic mushroom vacations come to the US? (The Washington Post)

• MycoMeditations' Psilocybin-Assisted Wellness Retreat Announces New Leadership and Its Early 2021 Program Calendar (PR Newswire)

• NeonMind Goes Public, Plans To Study Functional Mushrooms And Psilocybin As Treatments (Benzinga)

MDMA

• Field Trip Health Ltd. Announces Participation in a MAPS-sponsored Multi-Site Study of MDMA-Assisted Therapy to Treat Eating Disorders (Psilocybin Alpha)

DMT

• New Clinical Trial Explores Safety of DMT for Substance Use Disorders (Technology Networks)

5-MeO-DMT

• Hamilton Morris Synthesizes 5-MeO-DMT in “Pharmacopeia” (Psychedelic Science Review)

• A Look at: 5MEO: Are Some Doors Better Left Unopened? (Reality Sandwich)

Ketamine

• Repeated Ketamine Infusions Reduce Symptom Severity in Individuals With Chronic Post-Traumatic Stress Disorder (Newswise)

• Ethical Concerns About Marketing Ketamine as a Safe and Effective Antidepressant (Medium)

Miscellaneous

• Jake Angeli: The Psychedelic Guru Who Stormed The Capitol (Psymposia)

• Big pharma is about to tune in to the potential of psychedelics (WIRED)

• Clandestine chemistry and psychoactive drugs in film: Hamilton Morris talks about his career (Chemical and Engineering News)

• Best Music Playlists For Psychedelic Therapy Are Explored In New Johns Hopkins Study (Marijuana Moment)

• Mount Sinai Health System Launches Center for Psychedelic Research (Psilocybin Alpha)

• Tooth tartar could uncover the drug habits of ancient people (Science)

• Are the Subjective Effects of Psychedelics Necessary for Their Therapeutic Benefits? (Psychedelic Science Review)

• Oakland’s Next Step in Psychedelic Decriminalization Approved Unanimously by City Council (Lucid News)

• Neuroscientists believe deep neural networks could help illustrate how psychedelics alter consciousness (PsyPost)

• What Is Raphael Warnock’s Record on Drug Policy and Harm Reduction? (Filter)

• What do Alien Abduction and Psychedelic Experiences have in Common? Let Dr. John E. Mack’s Work Explain (Psychedelics Today)

• Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia (Psilocybin Alpha)

• God's Factory Reset (Reset.me)

• NeonMind Appoints Trevor Millar as Chief Psychedelic Officer (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.1.21

Cannabis

• New York Lawmakers Prefile Eight Marijuana Bills For 2021 As State Pursues Legalization (Marijuana Moment)

• New Jersey: Governor Delays Signing Adult-Use Legalization Legislation (NORML)

• Mississippi And South Dakota Officials Defend Marijuana Ballot Measures Against Legal Challenges (Marijuana Moment)

• Illinois Expunges Nearly Half a Million Cannabis Arrest Records 4 Years Ahead of Schedule (NBC Chicago)

• Montana: Adult-Use Legalization Law Takes Effect (NORML)

• Young Adults Who Vape Cannabis Are More Likely To Experience Cough, Bronchitis And Wheezing, Study Finds (CBS Baltimore)

• Missouri Lawmaker’s New Bill Would Put Marijuana Legalization On 2022 Ballot (Marijuana Moment)

• Study shows long-term cannabis use does not increase sensitivity to pain (The Spokesman-Review)

Magic Mushrooms

• 2020 Was the Year of the Magic Mushroom (VICE)

• Pure Extracts Commences Study on Psilocybin Oral Tablets, Capsules and Nasal Gel (Psilocybin Alpha)

• The Top 10 Psilocybin Research Papers of 2020 (Psychedelic Science Review)

MDMA

• A Brief History of the Netherlands' Love Affair With Ecstasy (VICE)

Ketamine

• Ketamine may ease depression by restoring the brain’s sensitivity to prediction error, study suggests (PsyPost)

• Is Ketamine Effective for Typical and Atypical Depression? (Psychology Today)

Datura

• Three hospitalised after eating datura at Christchurch prison (Radio New Zealand)

Miscellaneous

• D.C. Decriminalizes Possession Of Drug Paraphernalia And Promotes Harm Reduction (Marijuana Moment)

• One psychedelic experience may lessen trauma of racial injustice (Ohio State News)

• Why Canada Could Be Next To Allow Psychedelic Therapy (And How It’s Already Changing Lives) (Forbes)

• The Psychedelic Renaissance in 2020 (Psilocybin Alpha)

• The Crisis of “Soft” Drug Criminalization in Italy (Filter)

• Remembering the Late Michael Alig, King of the Club Kids, Ex-Con Killer… And Unconventional Psychedelic Pioneer (DoubleBlind)

• Psychedelics and Judaism (Reality Sandwich)

• Legal Psychedelic Therapy Comes to Alberta With Ground-Breaking Health Canada Decision (Psilocybin Alpha)

• Compassionate Use – Psychedelic Therapy for Those Who Can’t Wait (Psychedelic Science Review)

• How UK Club Bouncers Prey On People Who Use Drugs (Filter)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 12.25.20

Cannabis

• America's longest-serving marijuana prisoner freed after 31 years (The Guardian)

• Study: Long-Term Cannabis Use Associated with Reduced Symptoms in Patients with Post-Traumatic Stress (NORML)

• Australia weighs wide-ranging medical cannabis reforms (Marijuana Business Daily)

• Congressional Funding Bill Restores Financial Aid For Students With Drug Convictions, And Has Other Marijuana Provisions (Marijuana Moment)

• Cannabis may help reduce exposure to fentanyl among people taking opioid replacements, study finds (CBC)

• Maryland Lawmaker Files Marijuana Legalization Bill Ahead Of 2021 Session (Marijuana Moment)

• Survey: Majority in Germany still opposes adult-use cannabis legalization (Marijuana Business Daily)

• As Rhode Island Moves To Legalize Marijuana In 2021, Senate Leaders Back Private Sales Model (Marijuana Moment)

• Cannabis users ‘fail to grasp health risks of smoking,’ study says (The Guardian)

• Congressional Progressive Caucus Calls For Marijuana Legalization In First Six Months Of 2021 (Marijuana Moment)

• Cannabis: the problem with defining products around THC content (The Conversation)

Magic Mushrooms

• NH Supreme Court rules in favor of religious freedom to use psychedelic mushrooms (New Hampshire Union Leader)

• Psyched Wellness Commences Pre-Clinical Trials of Amanita Muscaria (Psilocybin Alpha)

MDMA

• Equity and Accessibility of MDMA-Assisted Therapy (Psychedelic Science Review)

Novel Psychoactive Substances

• Methoxetamine: Cousin of Ketamine (Psychedelic Science Review)

Ketamine

• Ketamine May Be More Effective Than Opioids for Prehospital Acute Pain (Clinical Pain Advisor)

• FDA Guidance Sought for Planned Trial of Ketamine to Treat Dyskinesia (Parkinson's News Today)

• Does Ketamine Have a Dark Side? (DoubleBlind)

Miscellaneous

• Mexico Lawmakers Reclaim Sovereignty From DEA (Filter)

• Remembering Psychedelic Activist and Drug Policy Pioneer Sheri Eckert, 1961-2020 (Lucid News)

• 2020’s Most Groundbreaking Developments in Psychedelics (Lucid News)

• Santa May Have Actually Been a Psychedelic Shaman (Playboy)

• New Congressional Bill Pressures States To Expunge Drug Convictions (Marijuana Moment)

• Lithium and Psychedelics (Spirit Pharmacist)

• Biden Promises Reform of His Punitive Drug Laws (Lucid News)

• How Anti-Racism is a Form of Psychedelic Harm Reduction (DoubleBlind)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.